Thermo Fisher (TMO) gains FDA pre-market approval for Oncomine Dx as companion diagnostic for Takeda’s EXKIVITY.
2021-09-16
Thermo Fisher’s (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY
Previous Post: Top Ranked Growth Stocks to Buy for September 16th